–
4D Molecular Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−71.3
FY22:
−110
FY23:
−113
FY24:
−188
FY25:
−160
(positive)
Change from FY21 to FY25
millions USD
FY21:
−68.3
FY22:
−106
FY23:
−107
FY24:
−181
FY25:
−152
(positive)
Change from FY21 to FY25
millions USD
FY21:
−71.3
FY22:
−107
FY23:
−101
FY24:
−161
FY25:
−140
(positive)
Change from FY21 to FY25
millions USD
FY21:
−71.3
FY22:
−107
FY23:
−101
FY24:
−161
FY25:
−140
All amounts in millions USD